LAS 30451: a novel 5-HT3 antagonist.
Martin
M
M
Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid, Spain.
Rosell
R
R
Guillem
V
V
Díaz-Rubio
E
E
Moreno
I
I
Soriano
V
V
Fernández
A
A
Pérez
A
A
D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001549:Benzamides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001643:Bridged Bicyclo Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D006801:Humans; D008297:Male; D011985:Receptors, Serotonin / Q000187:drug effects; D012702:Serotonin Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D000932:Antiemetics; D001549:Benzamides; D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; C078370:pancopride